We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

104 hedge funds and large institutions have $205M invested in Abeona Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

143% more call options, than puts

Call options by funds: $8.88M | Put options by funds: $3.65M

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

19% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 31

9% more capital invested

Capital invested by funds: $188M → $205M (+$17.3M)

4% more funds holding

Funds holding: 100 → 104 (+4)

2.45% more ownership

Funds ownership: 69.4% → 71.85% (+2.4%)

Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
22
Increased
37
Reduced
31
Closed
18
Calls
$8.88M
Puts
$3.65M
Net Calls
+$5.23M
Net Calls Change
-$1.39M

Top Buyers

1
ACM
AIGH Capital Management
Maryland
+$10.1M
2
CCC
Cable Car Capital
California
+$9.56M
3
TCM
Tang Capital Management
California
+$5.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.53M
5
Aberdeen Group
Aberdeen Group
United Kingdom
+$3.1M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$16.1M
2
WSL
Western Standard LLC
California
-$6.6M
3
BCM
Boone Capital Management
Georgia
-$2.66M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.07M
5
Bank of America
Bank of America
North Carolina
-$2.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$26.2M +$2.01M +398,387 +9%
BlackRock
2
BlackRock
New York
$16.7M +$64K +12,713 +0.4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$14.5M +$776K +154,242 +6%
SCM
4
Suvretta Capital Management
New York
$14.1M – – –
CCC
5
Cable Car Capital
California
$13.2M +$9.56M +1,900,000 +317%
ACM
6
AIGH Capital Management
Maryland
$10.5M +$10.1M +2,000,000 New
VC
7
Vivo Capital
California
$9.71M – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.99M +$50.3K +9,996 +0.9%
KCM
9
Kennedy Capital Management
Missouri
$5.53M -$3.87K -768 -0.1%
TCM
10
Tang Capital Management
California
$5.27M +$5.03M +1,000,000 New
NFT
11
Nan Fung Trinity
Hong Kong
$5.04M +$1.99M +396,000 +71%
State Street
12
State Street
Massachusetts
$4.73M +$918K +182,284 +25%
PBM
13
Propel Bio Management
California
$4.38M -$721K -143,242 -15%
AIC
14
AWM Investment Company
New York
$4.08M +$1.14M +227,130 +42%
6CM
15
683 Capital Management
New York
$4.06M – – –
SCM
16
Stonepine Capital Management
Oregon
$3.74M +$1.3M +258,535 +57%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$3.7M +$3.53M +701,288 New
DC
18
Diametric Capital
Massachusetts
$3.66M +$2.62M +521,220 +301%
SCM
19
Silverarc Capital Management
Massachusetts
$3.31M -$1.85M -367,016 -37%
Aberdeen Group
20
Aberdeen Group
United Kingdom
$3.25M +$3.1M +616,413 New
Balyasny Asset Management
21
Balyasny Asset Management
Illinois
$3.12M +$2.98M +591,737 New
Citigroup
22
Citigroup
New York
$2.75M -$14.4K -2,869 -0.5%
Bank of America
23
Bank of America
North Carolina
$2.68M -$2.04M -405,287 -44%
Goldman Sachs
24
Goldman Sachs
New York
$2.65M +$905K +179,753 +56%
SAM
25
Simplify Asset Management
Nevada
$2.64M -$326K -64,667 -11%
1
2 3 4 5

ABEO Hedge Fund Activity: Q4 2025 in Review

104 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2025, worth a combined $205M — up 9.2% from $188M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ABEO positions and 18 closed out — a net gain of 4 holders — while 37 added to existing stakes and 31 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $10.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $16.1M sold.

  • 104 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2025, up from 100 in Q3 2025.
  • Funds reported $205M of Abeona Therapeutics stock for Q4 2025, up 9.2% quarter-over-quarter.
  • 22 funds opened new Abeona Therapeutics positions in Q4 2025 and 18 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q4 2025 was AIGH Capital Management, an estimated $10.1M added.
  • The largest Abeona Therapeutics seller in Q4 2025 was Adage Capital Partners, an estimated $16.1M sold.

Based on aggregated 13F filings for Q4 2025.